financetom
Business
financetom
/
Business
/
Arch Capital Group Q2 Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Arch Capital Group Q2 Earnings, Revenue Rise
Jul 30, 2024 1:40 PM

04:29 PM EDT, 07/30/2024 (MT Newswires) -- Arch Capital Group ( ACGL ) reported Q2 after-tax operating income Tuesday of $2.57 per share, compared with $1.92 a year earlier.

Analysts surveyed by Capital IQ expected normalized earnings of $2.21 per share.

Net premiums written for the quarter ended June 30 was $3.78 billion, up from $3.43 billion a year ago.

Three analysts polled by Capital IQ expected revenue of $3.93 billion.

Price: 99.50, Change: +1.30, Percent Change: +1.32

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nurix Therapeutics Names New Board Chair
Nurix Therapeutics Names New Board Chair
May 20, 2024
04:41 PM EDT, 05/20/2024 (MT Newswires) -- Nurix Therapeutics ( NRIX ) said late Monday that David Lacey has stepped down as board chair following the conclusion of its annual stockholders' meeting. Lacey will remain on the board and will continue to chair the compensation committee and serve as a member of its development advisory committee, the company said. Nurix...
Sweetgreen Insider Sold Shares Worth $263,675, According to a Recent SEC Filing
Sweetgreen Insider Sold Shares Worth $263,675, According to a Recent SEC Filing
May 20, 2024
04:40 PM EDT, 05/20/2024 (MT Newswires) -- Mitch Reback, CFO, on May 16, 2024, sold 8,410 shares in Sweetgreen ( SG ) for $263,675. Following the Form 4 filing with the SEC, Reback has control over a total of 883,365 shares of the company, with 397,174 shares held directly and 486,191 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1477815/000141588924013770/xslF345X03/form4-05202024_080502.xml Price: 33.92, Change: +0.09,...
Ultragenyx must face Henrietta Lacks family lawsuit over HeLa cell profits
Ultragenyx must face Henrietta Lacks family lawsuit over HeLa cell profits
May 20, 2024
May 20 (Reuters) - The estate of Henrietta Lacks can move forward with a lawsuit against biopharmaceutical company Ultragenyx over the use of cells taken from Lacks' body in the 1950s, a Maryland federal court said on Monday. U.S. District Judge Deborah Boardman rejected Ultragenyx's motion to dismiss the case, ruling that the estate had plausibly claimed that Ultragenyx wrongly...
Transcat Q4 Adjusted EPS, Revenue Increase
Transcat Q4 Adjusted EPS, Revenue Increase
May 20, 2024
04:41 PM EDT, 05/20/2024 (MT Newswires) -- Transcat ( TRNS ) reported Q4 adjusted earnings late Monday of $0.66 per diluted share, up from $0.60 a year earlier. Three analysts polled by Capital IQ expected $0.66. Revenue for the quarter ended March 30 was $70.9 million, up from $62.1 million a year earlier. Analysts surveyed by Capital IQ expected $68.6...
Copyright 2023-2026 - www.financetom.com All Rights Reserved